Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target. Gould C, Lickiss J, Kankanige Y, Yerneni S, et al. Br J Haematol 2021;195:113-118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gould C, Lickiss J, Kankanige Y, Yerneni S, et al. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target. Br J Haematol 2021;195:113-118.
PMID: 34426978